Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-03 4:05 pm Purchase | 2025-12-31 | 13G | Strive, Inc. ASST | YA II PN Ltd. | 39,235,037 3.600% | 658,434 (+1.71%) | Filing History |
| 2026-01-13 4:23 pm Sale | 2025-12-31 | 13G | Faraday Future Intelligent Electric Inc. FFIE | YA II PN Ltd. | 0 0.000% | -114,198 (Position Closed) | Filing History |
| 2025-12-23 4:05 pm Purchase | 2025-12-19 | 13G | RedHill Biopharma Ltd. RDHL | YA II PN Ltd. | 508,723 9.900% | 508,723 (New Position) | Filing History |
| 2025-12-05 4:05 pm Sale | 2025-12-04 | 13G | AMERICA ACQ I CORP UNIT 1 NWAXU | YA II PN Ltd. | 1,490,000 4.900% | -1,507,000 (-50.28%) | Filing History |
| 2025-12-04 4:59 pm Purchase | 2025-12-04 | 13G | AMERICA ACQ I CORP UNIT 1 NWAXU | YA II PN Ltd. | 2,997,000 9.990% | 2,997,000 (New Position) | Filing History |
| 2025-10-17 7:40 pm Sale | 2025-09-30 | 13G | Sequans Communications S.A. SQNS | YA II PN Ltd. | 1,030,859 0.720% | -13,097,880 (-92.70%) | Filing History |
| 2025-10-17 7:39 pm Purchase | 2025-10-10 | 13G | Aurelion Inc. AURE | YA II PN Ltd. | 34,564,233 9.990% | 34,564,233 (New Position) | Filing History |
| 2025-10-07 6:36 pm Purchase | 2025-09-12 | 13G | Strive, Inc. ASST | YA II PN Ltd. | 38,576,603 9.900% | 38,576,603 (New Position) | Filing History |
| 2025-07-14 6:38 pm Purchase | 2025-07-07 | 13G | Sequans Communications S.A. SQNS | YA II PN Ltd. | 1,412,874 9.900% | 1,412,874 (New Position) | Filing History |
| 2025-07-08 2:11 pm Purchase | 2025-06-16 | 13G | Aptevo Therapeutics Inc. APVO | YA II PN Ltd. | 19,880 9.990% | 19,880 (New Position) | Filing History |
| 2025-04-01 4:09 pm Purchase | 2025-03-31 | 13G | Mobile-health Network Solutions Class A Ordinary Shares MNDR | YA II PN Ltd. | 63,308 9.990% | 63,308 (New Position) | Filing History |
| 2025-03-26 6:22 pm Purchase | 2025-03-24 | 13G | Scinai Immunotherapeutics Ltd. SCNI | YA II PN Ltd. | 93,274 9.900% | 93,274 (New Position) | Filing History |
| 2025-02-18 4:03 pm Purchase | 2025-02-13 | 13G | Indaptus Therapeutics, Inc. INDP | YA II PN Ltd. | 50,390 9.990% | 50,390 (New Position) | Filing History |
| 2025-02-06 4:03 pm Purchase | 2025-02-05 | 13G | Soluna Holdings, Inc. SLNH | YA II PN Ltd. | 1,059,641 9.990% | 1,059,641 (New Position) | Filing History |
| 2025-01-13 6:29 pm Sale | 2024-12-31 | 13G | Voyager Acquisition Corp. VACH | YA II PN Ltd. | 50,000 0.200% | -1,830,000 (-97.34%) | Filing History |
| 2025-01-13 6:27 pm Sale | 2024-12-31 | 13G | Helbiz, Inc. HLBZ | YA II PN Ltd. | 0 0.000% | -929,736 (Position Closed) | Filing History |
| 2024-12-18 08:05 am Purchase | 2024-12-13 | 13G | InMed Pharmaceuticals Inc. INM | YA II PN Ltd. | 80,372 9.990% | 80,372 (New Position) | Filing History |
| 2024-12-03 4:01 pm Sale | 2024-11-26 | 13G | FACT II Acquisition Corp. Unit FACTU | YA II PN Ltd. | 100,000 0.500% | -1,600,000 (-94.12%) | Filing History |
| 2024-11-29 1:18 pm Purchase | 2024-11-26 | 13G | FACT II Acquisition Corp. Unit FACTU | YA II PN Ltd. | 1,700,000 9.400% | 1,700,000 (New Position) | Filing History |
| 2024-11-06 1:59 pm Sale | 2024-09-30 | 13G | PHOENIX MTR INC PEVM | YA II PN Ltd. | 0 0.000% | -2,363,141 (Position Closed) | Filing History |